Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women ≤50 years at the time of admission with the ability to give informed con-sent.~* Admission for induction of labor or early spontaneous labor with cervix ≤3 cm.~* Diagnosed with bacterial vaginosis at time of admission or in the week prior to admission if not treated~* Gestational age ≥ 34 weeks~Exclusion Criteria:~* Spontaneous rupture of membranes~* Plan for elective cesarean delivery~* Allergy or contraindications to metronidazole~* Receipt of metronidazole or clindamycin in the admission for delivery for other in-dications.~* Hemodialysis~* Severe liver dysfunction~* Diagnosis of chorioamnionitis at the time of admission

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Control Arm (Type: PLACEBO_COMPARATOR): Placebo tablets oral, 4 tablets once.
- Treatment Arm (Type: ACTIVE_COMPARATOR): Will receive 4 tablets (2g) of metronidazole oral once.

Based on this trial design, predict the completion outcome and termination type (if applicable).